Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

[Preprint]. 2024 Sep 13:2024.08.19.608538. [Version 2] doi: 10.1101/2024.08.19.608538

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows reusers to copy and distribute the material in any medium or format in unadapted form only, for noncommercial purposes only, and only so long as attribution is given to the creator.

PMC Copyright notice

Figure 1: — a and b, Probability of progression-free survival (a) and overall survival (b) in a German cohort of patients receiving CAR T cells, depending on different antibiotic-(ABX)-treatment regimen. PIM (piperacillin/tazobactam, imipenem, meropenem); PFS, progression-free survival; OS, overall survival. c, Levels of multiple short-chain fatty acids following antibiotic exposure. d-g, Kaplan-Meier curves showing PFS (upper panel) and OS (lower panel) depending on the abundance of pentanoate (d), butyrate (e), propionate (f) and acetate (g). h,i Kaplan-Meier curves showing PFS (h) and OS (i) depending on the abundance of pentanoate in a US cohort.